The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions

Chimeric antigen receptor (CAR)-T cell therapy is effective in the treatment of refractory/relapsed (r/r) hematological malignancies (r/r B-cell lymphoblastic leukemia, B-cell lymphoma, and multiple myeloma). In addition, it is being explored as a treatment option for solid tumors. As of 31 March 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanping, Ming, Yue, Fu, Ruoqiu, Li, Chen, Wu, Yuanlin, Jiang, Tingting, Li, Ziwei, Ni, Rui, Li, Li, Su, Hui, Liu, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616161/
https://www.ncbi.nlm.nih.gov/pubmed/36313336
http://dx.doi.org/10.3389/fphar.2022.950923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616161/
https://www.ncbi.nlm.nih.gov/pubmed/36313336
http://dx.doi.org/10.3389/fphar.2022.950923

Ejemplares similares